{"id":5419,"date":"2024-05-01T17:35:07","date_gmt":"2024-05-01T17:35:07","guid":{"rendered":"https:\/\/medexperts.pro\/?p=5419"},"modified":"2024-05-01T18:25:58","modified_gmt":"2024-05-01T18:25:58","slug":"klobuchar-asks-regulators-to-investigate-multiplan-over-health-care-pricing","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=5419","title":{"rendered":"Klobuchar Asks Regulators to Investigate MultiPlan Over Health Care Pricing"},"content":{"rendered":"
<\/div>\n

A data analytics firm has helped big health insurers cut payments to doctors, raising concerns about possible price fixing.<\/p>\n

\n
\n
\n

Recent revelations about a data analytics firm\u2019s role in determining medical payments have heightened concerns about possible price fixing in health care and led to a call for a federal investigation.<\/p>\n

In a letter<\/a> this week, Senator Amy Klobuchar asked federal regulators to examine whether algorithms used by the firm, MultiPlan, have helped major health insurers conspire to cut payments to doctors and leave patients with large bills. She cited a New York Times investigation<\/a> last month into MultiPlan\u2019s dominance of the lucrative business of pricing out-of-network medical claims.<\/p>\n

\u201cAlgorithms should be used to make decisions more accurate, appropriate and efficient, not to allow competitors to collude to make health care more costly for patients,\u201d Ms. Klobuchar wrote to the heads of the Justice Department\u2019s antitrust division and the Federal Trade Commission.<\/p>\n

When patients see a medical provider outside their plan\u2019s network, insurers often send their claims to MultiPlan, which uses proprietary algorithms to recommend how much to pay. By driving down payments to providers, MultiPlan and the insurers can collect higher fees for themselves, The Times reported, but this can lead to higher bills for patients, who may get charged the unpaid balance.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

UnitedHealthcare, Cigna, Aetna and other major insurers use MultiPlan\u2019s pricing recommendations, and the firm has boasted to investors that it is \u201cdeeply embedded\u201d in its clients\u2019 claims-processing systems.<\/p>\n

In interviews, Ms. Klobuchar, a Democrat from Minnesota, and experts in antitrust law said this arrangement could amount to price fixing: Rather than competing to offer better coverage, insurers could use the low prices recommended by MultiPlan\u2019s algorithms, knowing their competitors would likely do the same.<\/p>\n

\u201cThis should trigger an investigation by the agencies,\u201d said Barak Orbach, a law professor at the University of Arizona. \u201cThere seems to be a really strong case.\u201d<\/p>\n

The F.T.C. and Justice Department declined to comment, but both agencies have raised concerns in the past about similar arrangements in other industries.<\/p>\n<\/div>\n<\/div>\n

\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>
\u201cAlgorithms should be used to make decisions more accurate, appropriate and efficient, not to allow competitors to collude to make health care more costly for patients,\u201d Senator Amy Klobuchar wrote in a letter to antitrust regulators.<\/span>Valerie Plesch for The New York Times<\/span><\/span><\/span><\/figcaption><\/figure>\n<\/div>\n<\/div>\n
\n
\n

MultiPlan did not have an immediate comment. But in legal filings, the firm has denied allegations of collusion and said that insurers are free to reject its pricing recommendations or negotiate higher payments with providers.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

The firm said in a previous statement to The Times that its work benefits patients and employers who pay for their workers\u2019 coverage by \u201cpromoting affordability, efficiency and fairness across the U.S. health care system.\u201d<\/p>\n

Insurers have said that MultiPlan\u2019s tools help combat outrageous billing by some providers, including consolidated hospital systems and private-equity-backed staffing firms.<\/p>\n

Documents reviewed by The Times indicate that MultiPlan has sometimes told insurers how their unnamed competitors were using the firm\u2019s pricing tools. In a 2017 presentation to UnitedHealthcare, MultiPlan shared \u201cRecent Client Strategies to Improve Results,\u201d which included techniques that could reduce payments to providers.<\/p>\n

After a 2019 meeting, a UnitedHealthcare senior vice president reported to her colleagues that a MultiPlan executive \u201cdid not specifically name competitors but from what he did say we were able to glean who was who.\u201d She then described how Cigna, Aetna and some Blue Cross Blue Shield plans were apparently using the firm\u2019s pricing tools.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

Three hospital systems have sued MultiPlan, accusing it of colluding with major insurers to set unreasonably low payments for medical care, and patients and providers have complained to the F.T.C. about MultiPlan, records obtained through a public records request show.<\/p>\n

One provider reported slashed payments from UnitedHealthcare, Cigna and an Aetna subsidiary after the insurers routed claims to MultiPlan\u2019s most aggressive pricing tool<\/a>. Another said the tool \u201chas decimated my life\u201d and caused \u201cthe closing of my business,\u201d which has \u201cleft patients having to travel 2.5 hrs for surgery.\u201d<\/p>\n

Patients complained to the agency of receiving large bills after insurers used MultiPlan-recommended prices. \u201cThis is now affecting my credit score,\u201d wrote one patient, describing a bill that had been sent to a debt collector. Another reported being billed thousands of dollars \u201csince they refuse to pay my providers the correct amount.\u201d<\/p>\n

Pricing algorithms have driven MultiPlan\u2019s growth over the past 15 years. The firm previously focused on controlling costs by negotiating with medical providers, but after being sold to private equity investors, it embraced automated, algorithm-based tools, which typically yield lower payment recommendations.<\/p>\n

Access to data from hundreds of clients has helped entrench the firm\u2019s dominance, executives have told investors. \u201cWe build our algorithms on a much larger data lake,\u201d one executive said in a 2020 presentation.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

The focus on MultiPlan\u2019s automated pricing tools highlights growing concern among regulators and some in Congress that algorithms are supercharging price-fixing schemes and driving up costs for consumers.<\/p>\n

During the Biden administration, companies\u2019 increasing embrace of technological advancements has collided with aggressive enforcement efforts by regulators. The results have been mixed, as the agencies seek to apply laws enacted to combat 19th-century oil and railroad robber barons to 21st-century technology firms.<\/p>\n

\u201cAlgorithms are the new frontier,\u201d the Justice Department wrote in a brief in one case. \u201cAnd, given the amount of information an algorithm can access and digest, this new frontier poses an even greater anticompetitive threat than the last.\u201d<\/p>\n

Regulators and some antitrust scholars worry that algorithms can enable sophisticated collusion that is difficult to police. Competitors no longer need to meet in secret to hatch a conspiracy and communicate among themselves to perpetuate it. They can simply agree to use a common pricing algorithm.<\/p>\n

Weighing in on private lawsuits involving apartment rents<\/a> and hotel room prices<\/a>, the agencies have argued that such an arrangement is illegal, even if competitors agree with a wink and a nod rather than a formal pact.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

But in one case, a judge disagreed in a December ruling, allowing the lawsuit to go forward but requiring renters to offer more explicit evidence that landlords had conspired to raise prices<\/a> using an algorithm.<\/p>\n

Ms. Klobuchar has introduced legislation<\/a> that would effectively make the agencies\u2019 position the default. Courts would presume it illegal for competitors to share nonpublic data with a middleman and use the pricing recommendations that the firm\u2019s algorithms produced.<\/p>\n

\u201cIt is not clear whether current antitrust laws are sufficient to stop this practice,\u201d Ms. Klobuchar said in an interview. \u201cIt is much better just to clarify this and to close the loophole.\u201d<\/p>\n

The bill would also require companies to tell consumers if they are buying something that was priced using an algorithm, and it would give regulators greater authority to demand details about how an algorithm works.<\/p>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

A data analytics firm has helped big health insurers cut payments to doctors, raising concerns about possible price fixing.Recent revelations about a data analytics firm\u2019s role in determining medical payments have heightened concerns about possible price fixing in health care and led to a call for a federal investigation.In a letter this week, Senator Amy Klobuchar asked federal regulators to examine whether algorithms used by the firm, MultiPlan, have helped major health insurers conspire to cut payments to doctors and leave patients with large bills. She cited a New York Times investigation last month into MultiPlan\u2019s dominance of the lucrative business of pricing out-of-network medical claims.\u201cAlgorithms should be used to make decisions more accurate, appropriate and efficient, not to allow competitors to collude to make health care more costly for patients,\u201d Ms. Klobuchar wrote to the heads of the Justice Department\u2019s antitrust division and the Federal Trade Commission.When patients see a medical provider outside their plan\u2019s network, insurers often send their claims to MultiPlan, which uses proprietary algorithms to recommend how much to pay. By driving down payments to providers, MultiPlan and the insurers can collect higher fees for themselves, The Times reported, but this can lead to higher bills for patients, who may get charged the unpaid balance.UnitedHealthcare, Cigna, Aetna and other major insurers use MultiPlan\u2019s pricing recommendations, and the firm has boasted to investors that it is \u201cdeeply embedded\u201d in its clients\u2019 claims-processing systems.In interviews, Ms. Klobuchar, a Democrat from Minnesota, and experts in antitrust law said this arrangement could amount to price fixing: Rather than competing to offer better coverage, insurers could use the low prices recommended by MultiPlan\u2019s algorithms, knowing their competitors would likely do the same.\u201cThis should trigger an investigation by the agencies,\u201d said Barak Orbach, a law professor at the University of Arizona. \u201cThere seems to be a really strong case.\u201dThe F.T.C. and Justice Department declined to comment, but both agencies have raised concerns in the past about similar arrangements in other industries.\u201cAlgorithms should be used to make decisions more accurate, appropriate and efficient, not to allow competitors to collude to make health care more costly for patients,\u201d Senator Amy Klobuchar wrote in a letter to antitrust regulators.Valerie Plesch for The New York TimesMultiPlan did not have an immediate comment. But in legal filings, the firm has denied allegations of collusion and said that insurers are free to reject its pricing recommendations or negotiate higher payments with providers.The firm said in a previous statement to The Times that its work benefits patients and employers who pay for their workers\u2019 coverage by \u201cpromoting affordability, efficiency and fairness across the U.S. health care system.\u201dInsurers have said that MultiPlan\u2019s tools help combat outrageous billing by some providers, including consolidated hospital systems and private-equity-backed staffing firms.Documents reviewed by The Times indicate that MultiPlan has sometimes told insurers how their unnamed competitors were using the firm\u2019s pricing tools. In a 2017 presentation to UnitedHealthcare, MultiPlan shared \u201cRecent Client Strategies to Improve Results,\u201d which included techniques that could reduce payments to providers.After a 2019 meeting, a UnitedHealthcare senior vice president reported to her colleagues that a MultiPlan executive \u201cdid not specifically name competitors but from what he did say we were able to glean who was who.\u201d She then described how Cigna, Aetna and some Blue Cross Blue Shield plans were apparently using the firm\u2019s pricing tools.Three hospital systems have sued MultiPlan, accusing it of colluding with major insurers to set unreasonably low payments for medical care, and patients and providers have complained to the F.T.C. about MultiPlan, records obtained through a public records request show.One provider reported slashed payments from UnitedHealthcare, Cigna and an Aetna subsidiary after the insurers routed claims to MultiPlan\u2019s most aggressive pricing tool. Another said the tool \u201chas decimated my life\u201d and caused \u201cthe closing of my business,\u201d which has \u201cleft patients having to travel 2.5 hrs for surgery.\u201dPatients complained to the agency of receiving large bills after insurers used MultiPlan-recommended prices. \u201cThis is now affecting my credit score,\u201d wrote one patient, describing a bill that had been sent to a debt collector. Another reported being billed thousands of dollars \u201csince they refuse to pay my providers the correct amount.\u201dPricing algorithms have driven MultiPlan\u2019s growth over the past 15 years. The firm previously focused on controlling costs by negotiating with medical providers, but after being sold to private equity investors, it embraced automated, algorithm-based tools, which typically yield lower payment recommendations.Access to data from hundreds of clients has helped entrench the firm\u2019s dominance, executives have told investors. \u201cWe build our algorithms on a much larger data lake,\u201d one executive said in a 2020 presentation.The focus on MultiPlan\u2019s automated pricing tools highlights growing concern among regulators and some in Congress that algorithms are supercharging price-fixing schemes and driving up costs for consumers.During the Biden administration, companies\u2019 increasing embrace of technological advancements has collided with aggressive enforcement efforts by regulators. The results have been mixed, as the agencies seek to apply laws enacted to combat 19th-century oil and railroad robber barons to 21st-century technology firms.\u201cAlgorithms are the new frontier,\u201d the Justice Department wrote in a brief in one case. \u201cAnd, given the amount of information an algorithm can access and digest, this new frontier poses an even greater anticompetitive threat than the last.\u201dRegulators and some antitrust scholars worry that algorithms can enable sophisticated collusion that is difficult to police. Competitors no longer need to meet in secret to hatch a conspiracy and communicate among themselves to perpetuate it. They can simply agree to use a common pricing algorithm.Weighing in on private lawsuits involving apartment rents and hotel room prices, the agencies have argued that such an arrangement is illegal, even if competitors agree with a wink and a nod rather than a formal pact.But in one case, a judge disagreed in a December ruling, allowing the lawsuit to go forward but requiring renters to offer more explicit evidence that landlords had conspired to raise prices using an algorithm.Ms. Klobuchar has introduced legislation that would effectively make the agencies\u2019 position the default. Courts would presume it illegal for competitors to share nonpublic data with a middleman and use the pricing recommendations that the firm\u2019s algorithms produced.\u201cIt is not clear whether current antitrust laws are sufficient to stop this practice,\u201d Ms. Klobuchar said in an interview. \u201cIt is much better just to clarify this and to close the loophole.\u201dThe bill would also require companies to tell consumers if they are buying something that was priced using an algorithm, and it would give regulators greater authority to demand details about how an algorithm works.<\/p>\n","protected":false},"author":1,"featured_media":5421,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[],"class_list":["post-5419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/5419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5419"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/5419\/revisions"}],"predecessor-version":[{"id":5422,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/5419\/revisions\/5422"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/5421"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}